PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
46.94
+1.86 (4.13%)
Apr 15, 2025, 4:00 PM EDT - Market closed

PTC Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 63.77, with a low estimate of 42 and a high estimate of 113. The average target predicts an increase of 35.85% from the current stock price of 46.94.

Analyst Consensus: Buy
Target Low Average Median High
Price $42 $63.77 $63 $113
Change -10.52% +35.85% +34.21% +140.73%

Analyst Ratings

The average analyst rating for PTC Therapeutics stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 222222
Buy 455666
Hold 433233
Sell 111100
Strong Sell 222222
Total 131313131313

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Maintains
$78$75
Buy Maintains $78$75 +59.78% Mar 31, 2025
JP Morgan
JP Morgan
Buy
Maintains
$72$78
Buy Maintains $72$78 +66.17% Mar 14, 2025
B of A Securities
B of A Securities
Hold
Upgrades
$41$55
Hold Upgrades $41$55 +17.17% Mar 11, 2025
Scotiabank
Scotiabank
Hold
Initiates
$55
Hold Initiates $55 +17.17% Mar 7, 2025
Morgan Stanley
Morgan Stanley
Buy
Initiates
$67$70
Buy Initiates $67$70 +49.13% Mar 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
734.57M
from 806.78M
Decreased by -8.95%
Revenue Next Year
858.89M
from 734.57M
Increased by 16.92%
EPS This Year
-3.05
from -4.73
EPS Next Year
-2.24
from -3.05
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
380.77M538.59M698.80M937.82M806.78M734.57M858.89M1.11B
Revenue Growth
24.04%41.45%29.75%34.20%-13.97%-8.95%16.92%29.47%
EPS
-6.64-7.43-7.79-8.37-4.73-3.05-2.24-0.08
EPS Growth
--------
Forward PE
--------
No. Analysts -----181815
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 813.7M 1.0B 1.7B
Avg 734.6M 858.9M 1.1B
Low 642.5M 708.7M 816.8M

Revenue Growth

Revenue Growth 20252026202720282029
High
0.9%
39.1%
92.8%
Avg
-9.0%
16.9%
29.5%
Low
-20.4%
-3.5%
-4.9%

EPS Forecast

EPS 20252026202720282029
High 7.22 5.93 9.50
Avg -3.05 -2.24 -0.08
Low -7.44 -7.22 -6.32

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.